Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Azathioprine therapy selectively ablates human Vd2? T cells in Crohn's disease.

Azathioprine therapy selectively ablates human Vd2? T cells in Crohn's disease. J Clin Invest. 2015 Aug 03; 125(8):3215-25.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.